Myriad Genetics Inc (MYGN)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	585,400	569,500	554,000	532,600	517,000	505,900	477,600	481,500	476,400	467,500	481,000	487,100	493,000	485,500	467,000	387,800	378,900	416,900	452,500	560,800
Revenue (ttm)	US$ in thousands	837,600	823,600	802,200	774,200	753,200	734,400	698,900	694,700	678,400	661,400	672,300	682,400	690,600	684,400	662,300	566,100	557,000	597,500	638,600	760,800
Gross profit margin		69.89%	69.15%	69.06%	68.79%	68.64%	68.89%	68.34%	69.31%	70.22%	70.68%	71.55%	71.38%	71.39%	70.94%	70.51%	68.50%	68.03%	69.77%	70.86%	73.71%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $585,400K ÷ $837,600K
= 69.89%

Myriad Genetics Inc's gross profit margin has shown some fluctuations over the periods from March 31, 2020, to December 31, 2024. The trend indicates a gradual decline from 73.71% in March 2020 to 69.89% by December 2024, with some variations in between.

The gross profit margin reached its lowest point of 68.03% in December 2020 but gradually improved to hit a peak of 71.55% in June 2022. Following this peak, there was a slight decrease before stabilizing around the range of 68.34% to 69.89% from March 2023 to December 2024.

Overall, while there have been fluctuations, the company has managed to maintain a gross profit margin above 68% throughout the analyzed period. This trend indicates the company's ability to effectively manage its production and operational costs relative to its revenue generation.